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Aberrant photoreceptor function or morphogenesis leads to blinding retinal degenerative diseases, 
the majority of which have a genetic aetiology. A variant in PRCD previously identified in Portuguese 
Water Dogs (PWDs) underlies prcd (progressive rod‑cone degeneration), an autosomal recessive 
progressive retinal atrophy (PRA) with a late onset at 3–6 years of age or older. Herein, we have 
identified a new form of early‑onset PRA (EOPRA) in the same breed. Pedigree analysis suggested 
an autosomal recessive inheritance. Four PWD full‑siblings affected with EOPRA diagnosed at 
2–3 years of age were genotyped (173,661 SNPs) along with 2 unaffected siblings, 2 unaffected 
parents, and 15 unrelated control PWDs. GWAS, linkage analysis and homozygosity mapping defined 
a 26‑Mb candidate region in canine chromosome 20. Whole‑genome sequencing in one affected 
dog and its obligatory carrier parents identified a 1 bp insertion (CFA20:g.33,717,704_33,717,70
5insT (CanFam3.1); c.2262_c.2263insA) in CCDC66 predicted to cause a frameshift and truncation 
(p.Val747SerfsTer8). Screening of an extended PWD population confirmed perfect co‑segregation 
of this genetic variant with the disease. Western blot analysis of COS‑1 cells transfected with 
recombinant mutant CCDC66 expression constructs showed the mutant transcript translated into 
a truncated protein. Furthermore, in vitro studies suggest that the mutant CCDC66 is mislocalized 
to the nucleus relative to wild type CCDC66. CCDC66 variants have been associated with inherited 
retinal degenerations (RDs) including canine and murine ciliopathies. As genetic variants affecting 
the primary cilium can cause ciliopathies in which RD may be either the sole clinical manifestation or 
part of a syndrome, our findings further support a role for CCDC66 in retinal function and viability, 
potentially through its ciliary function.
In the vertebrate retina, conversion of the optical image into neural impulses is initiated by rod and cone pho-
toreceptors, whose main role is to capture and transduce photons into neuronal signals. Photoreceptors are 
highly polarized, light-sensitive neurons whose structure is composed of four distinct compartments: the outer 
 segment1, the mitochondria-rich inner segment, the cell body harbouring the nucleus, and the synaptic body, 
which extends to synapse with second order  neurons2,3. Photoreceptors are located adjacent to the retinal pig-
ment epithelium, a cell layer that is vital for their maintenance and survival. Aberrant morphogenesis and 
development of rod and/or cone photoreceptors (and of their synaptic connections to second order neurons) 
can cause retinal degeneration (RD) that is progressive and ultimately leads to blindness. The aetiology behind 
RDs is often genetic in nature, making RDs predominantly inherited diseases. While past studies on RD often 
focused on the photoreceptors themselves, there has been increasing interest in the connecting cilium, which 
bridges the outer and inner segments of the photoreceptor and play a critical role in photoreceptor integrity and 
 maintenance4–6. Connecting cilia have a structure analogous to primary sensory cilia in other cell  types4–6 and 
inherited defects in primary cilia cause a class of inherited conditions known as ciliopathies, in which retinal 
dystrophy and degeneration are often, albeit not necessarily, part of a syndromic  phenotype7,8.
OPEN
1Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia, PA, USA. 2Institute of Genome Biology, Leibniz Institute for Farm Animal Biology, 
Dummerstorf, Germany. 3Institute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland. 4Optigen, 
LLC, Ithaca, NY, USA. *email: kmiya@upenn.edu
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
9
1
2
4
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
2
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21162  | https://doi.org/10.1038/s41598-020-77980-5
www.nature.com/scientificreports/
The number of genes and loci associated with inherited retinal diseases, including RDs, in people is greater 
than 300 (RetNet: https ://sph.uth.edu/RETNE T/, accessed 9/24/2020) and an increasing number of comparable 
diseases are also recognized in non-human mammals. Indeed, variants in more than 30 genes have been associ-
ated with different forms of inherited retinal diseases in dogs, most of which are RDs and are referred to as pro-
gressive retinal atrophy (PRA) in veterinary  medicine9 (ExpeRTs: https ://www.vet.upenn .edu/exper ts, accessed 
9/24/2020). PRA can be diagnosed in virtually any canine breed and its molecular cause may be related to one of 
the 30+ known breed-specific disease variants or driven by variants yet to be discovered. Investigation into the 
molecular basis of blinding retinal diseases in dogs is vital for the welfare and health of numerous breeds. Fur-
thermore, dogs are invaluable animal models for the development of therapies that can be translated into a clinical 
 setting10–12, providing essential insight into the molecular players and mechanisms driving RDs in  humans13–15.
While the impact of a genetic variant on the nature and severity of pathogenesis can sometimes be  inferred16, 
there are over 3000 domain of unknown function (DUF) families estimated to exist within the Pfam  database17 
representing roughly 22% of known protein families in eukaryotic  organisms18. Characterization of DUFs and 
further elucidation of their structure/function relationship is an important aim in structural  genomics19,20. As 
shown previously by Veermer and colleagues, utilization of mapping techniques in combination with sequencing 
can identify causative genes for autosomal-recessive diseases, and help pinpoint a poorly characterized putative 
domain associated with a pathological condition. This type of breakthrough can ultimately pave the way for 
discovery and characterization of new signalling  pathways21,22.
The Portuguese Water Dog (PWD) population, although once fairly small, has gained popularity in recent 
years, in part due to its ‘hypoallergenic’ nature and increasing media exposure. The breed originates from three 
major founding events involving two different  kennels23–25. The PWD breed offers some specific advantages over 
other breeds for the study of complex traits such as Addison’s  disease24, as the bottlenecks and founder effects in 
the current breed population is considered to have resulted in limited genetic  variation24,26,27. Fortunately, the 
PWD breeding community has been highly motivated and involved in improving the health of the breed, and 
readily participates in genetic screening of their dogs.
PRA has been diagnosed in a variety of dog breeds and is homologous to human inherited RDs such as 
retinitis pigmentosa (RP). While most forms of PRA are inherited in an autosomal recessive manner, an auto-
somal dominant variant of rhodopsin has been reported in Mastiffs 28 and X-linked PRA variants have also 
been  identified21,29. There are more than 38 described genetic variants that either cause independent forms of 
Mendelian PRAs or function as disease modifiers to alter disease  expression30–33. Among the canine population, 
it is not uncommon for a given form of PRA caused by a specific genetic variant to be found in multiple breeds 
that share a common origin. In established breeds, it was originally thought that a single gene variant found to 
segregate with PRA in a given breed would likely explain most, if not all, the PRA cases in that breed due to the 
within-breed genetic uniformity resulting from population bottlenecks affected by founder effects and popular 
sires. The inter-breed ‘genetic barriers’ implemented by the breeders and breed clubs for the establishment, pres-
ervation, and enhancement of canine breeds thus contributed to keeping the variant within the breed. However, 
with advances in tools available for genomic and genetic analyses, some breeds are found to have more than one 
forms of PRA segregating in the  population14. Examples of breeds with multiple forms of PRAs characterized 
at the gene mutation level include Golden Retrievers (PRCD, TTC8, and SLC4A3)34–36, Irish Setters (PDE6B 
and C2ORF71) 37,38, and Miniature Schnauzers (RPGR and HIVEP3-PPT1)36,39. Such findings suggest deliberate 
breeding practices associated with breed establishment and the subsequent breed  isolation14 fixed multiple PRA 
segregating genes within these populations.
Prior to the current study, it was known that prcd-PRA (progressive rod-cone degeneration-PRA) segregated 
in PWDs as an autosomal recessive, late-onset PRA, recognized clinically at 3–6 years or  older14,40 .This disease 
is associated with a PRCD genetic variant that is considered to have a relatively ancient origin and shared by 
nearly 60 diverse canine breeds and their  crosses36,41 (ExpeRTs, www.vet.upenn .edu/exper ts, accessed 9/24/2020). 
Herein we report a new form of RD in PWDs that is not associated with PRCD and is characterized by an earlier 
disease onset. We performed a genome-wide association study (GWAS) and whole-genome sequencing (WGS), 
and identified the causative genetic variant in CCDC66, a gene that has been associated with RDs specifically 
related to defective ciliary function in mouse models as well as in another form of canine  RD42.
Results
Phenotypic characterization of early‑onset PRA (EOPRA) in PWDs. A total of 4 cases (2 males, 2 
females), all full-siblings, from a small consanguineous pedigree were diagnosed with EOPRA (Fig. 1).
The initial clinical signs noticed in affected dogs by the owners were visual deficits, including difficulty fol-
lowing moving objects and walking into still objects, which were reportedly worse under dim light, consistent 
with nyctalopia. These signs became progressively worse, compromising the animals’ vision under both dim 
and well-lit conditions. The age of onset was determined by the time point at which the visual deficits became 
noticeable to the owners or when ophthalmoscopic abnormalities were first noted. The male proband and the 
two affected females had decreased vision per the owner at initial presentation and were diagnosed ophthalmo-
scopically as EOPRA with an age of onset at 2 years. A second male dog had no obvious visual deficit per the 
owner at initial presentation at age 2 years and had unremarkable fundus when examined ophthalmoscopically. 
However, peripapillar changes suggestive of PRA developed by 3 years of age at which time electroretinography 
(ERG) was recommended but declined. This dog was re-examined at 6 years of age when visual impairment was 
evident, ERGs were undetectable (Supplementary Fig. 1), and ophthalmoscopic changes were consistent with 
mid-stage disease. The ophthalmoscopic changes observed were common in all affected dogs, characterized by 
generalized tapetal hyper-reflectivity, diffuse vascular attenuation, optic disc pallor, and multifocal depigmenta-
tion of the non-tapetal fundus (Fig. 2, images by the authors).
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A feature that was unique to this disease in all affected dogs was a distinct peripapillary ring of hyper-reflec-
tivity or peripapillary conus (Fig. 2A1,B), which progressed into a broader zone of hyper-reflectivity around the 
optic disc in advanced disease (Fig. 2A2,C,D; details of the non-tapetal fundus in Fig. 2E). Other than the visual 
deficits, fundus abnormalities, and a sluggish pupillary light reflex, the remainder of the ophthalmic exam was 
within normal limits except for cataract formation with equatorial vacuoles in one dog at an advanced stage 
of disease. Functional assessment of the retina was carried out in one of the affected dogs (male dog, onset at 
3 years) at a single later follow-up time point at age 6 years revealing undetectable scotopic and photopic ERGs 
(Supplementary Fig. 1). Of note, no other clinical abnormalities were identified or reported in the dogs affected 
with EOPRA.
Pedigree analysis suggested an autosomal recessive mode of inheritance based on the phenotypically normal 
parents of the affected dogs, with both male and female affected individuals (Fig. 1). The pedigree information 
revealed a recent common ancestor which was the shared sire of the obligatory carrier parents who were half-
siblings. However, subsequent molecular analysis revealed that this recent common ancestor did not carry the 
disease allele, suggesting that the disease variant may be present more widely across the PWD population.
Mapping of the critical candidate region. Typing for the known PRCD disease variant did not reveal 
the mutant PRCD allele in any of the PRA-affected PWDs in the pedigree, suggesting a new inherited disease. 
Hypothesizing a simple Mendelian recessive inheritance, 4 cases and 19 controls derived from both closely and 
distantly related PWD dogs were genotyped using an Illumina Canine 170 k SNP chip. After removing 103,281 
non-informative markers (due to the closely related nature of the population), 70,380 SNPs were used for GWAS 
mapping. The estimated lambda was 1.33, showing an expected degree of population stratification. While no 
statistically significant association was found with the disease, we detected possible suggestive peaks on canine 
chromosomes (CFA) 20 (p value = 0.00014), and 11 (p value = 0.00059) (Fig. 3A). The top 100 associated markers 
were all on CFA20. Due to the stratification and low power of the results, these GWAS hits were only considered 
as indicative, and therefore we opted to undertake additional mapping strategies.
As the first additional mapping approach, multipoint parametric linkage was carried out in a subset of closely-
related PWD dogs (2 parents, 4 affected and 2 unaffected full-siblings). This revealed positive LOD scores on 
CFA2, CFA12 and CFA20. For the purpose of mapping, intervals with positive LOD scores and the α = 1 were 
considered relevant. A 20.63 Mb interval on CFA20 (CFA20: 29.33–49.96 Mb) was found to have the highest 
LOD score of 2.501 (Fig. 3B). The maximum LOD scores on CFA2 (2.43 Mb interval, position 54.97–57.40 Mb) 
and CFA12 (1.96 Mb interval, position 64.06–66.02 Mb) were 0.914 and 1.190, respectively.
As we hypothesized monogenic recessive inheritance based on the observed disease segregation, we expected 
that the disease allele and flanking chromosomal segments in the affected animals would be identical by descent 
(IBD). Therefore, we searched for extended regions of homozygosity (> 1 Mb) with simultaneous allele shar-
ing. The 4 cases that were full siblings shared a homozygous region on CFA20, spanning from 21,911,990 
(BICF2G630233682) to 48,461,664 bp (BICF2P389157).
Variant detection and CCDC66 annotation. Combining all the information from the different mapping 
strategies, the interval on CFA20 shared between all 4 cases was deemed the most likely to be associated with the 
disease (Fig. 3C). Hence the search for disease variants was thereafter focused on the 26.55 Mb critical interval 
Figure 1.  Family tree of the four affected PWDs and their close relatives. The dogs indicated with the blue filled 
symbol are clinically affected with EOPRA and are homozygous for the insertion allele (CFA20:g.33,717,704
_33,717,705insT, CanFam3.1) in CCDC66. The half-filled symbols indicate clinically unaffected carriers that 
included the parents who are obligate carriers, and one of the unaffected siblings later genotyped as a carrier. 
Unknown status is indicated with a question mark for dogs that were not examined clinically. Dogs indicated 
with an asterisk (*) were used in WGS. The family tree shows a common sire of the parents that are half-siblings. 
Females are shown as circles, males in squares.
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on CFA20 (using the last heterozygous markers before and after the homozygous segment, BICF2G630233693 
and chr20_48467358, ultimately CFA20:21,904,057–48,467,358 bp) established by homozygosity mapping. The 
variant calls resulting from WGS of three selected PWDs (1 affected dog and 2 obligate carrier parents) were 
filtered from an extended database of the Dog Biomedical Variant Database Consortium (DBVDC)45. Addition-
ally, we checked for the presence of the variant in the idog (http://bigd.big.ac.cn/idog/, accessed 9/24/2020) and 
EVA databases (European Variant Database, see methods). The variants exclusive to the three PWDs in our WGS 
dataset amounted to 33,205.
Through filtering of the variants according to the assumed autosomal recessive inheritance mechanism, we 
found that 158 of these variants were homozygous in the affected dog and heterozygous in the obligate carri-
ers. Finally, we searched for the variants predicted to have an impact on the coding sequence of the protein. 
Figure 2.  Fundus photographs of PWDs affected with CCDC66-EOPRA. (A) Peripapillary (upper images) 
and non-tapetal (lower images) images of an EOPRA-affected dog presenting with early- (A1) and mid-stage 
(A2) disease at 2 and 4 years of age, respectively. Disease stage is based on fundus appearance, with early 
disease corresponding to 3–4 ONL nuclei, mid disease corresponding to 1–2 ONL nuclei, and late disease 
corresponding to 0–1 ONL  nucleus43. The ring-like hyperreflectivity of the peripapillary tapetal region has 
expanded over time. There is also progression of the multifocal depigmentation in the non-tapetal region. (B) 
Fundus photographs of an EOPRA-affected dog presenting mid-stage disease at 6 years of age. This dog was 
reported to have normal vision but exhibited early changes of retinal degeneration at 3 years of age. (C) Late-
stage disease fundus of the right (C1) and left (C2) eyes in an affected dog at 4 years of age, corresponding to 
0–1 ONL  nucleus43. (D) Details of the peripapillary region in the right eye shown in (C) with distinct, ring-like 
hyperreflectivity, vascular attenuation, optic disc pallor, and pigment clumping. (E) Details of the non-tapetal 
fundus in the left eye shown in (C) with extensive depigmentation (pale brown-grey), intraretinal pigment 
clumping, and visualization of the choroidal vasculature. Fundus images were obtained using the Genesis 
fundus camera by direct photography or indirect photography through a 20D condensing  lens44.
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Figure 3.  Genome-wide mapping of EOPRA. (A) Results of the genome-wide association study (GWAS) obtained from 
analyzing the Illumina SNP chip data showing the negative log of the raw p values calculated with the genotypic association 
test (minimum p value = 0.0001400861). Top right, QQ-plot showing the expected quantiles (x axis) of the log p values versus 
the observed (y axis). The moderate skewing of a marker toward the upper side suggests a weak association with the “affected” 
condition compared with what would be expected by mere chance. The flat-line at expected − log(p value) = 3.85 (highest p 
value reported of 0.00014) is likely caused by the high stratification thus justifying the complementary mapping methods used. 
(B) Multipoint parametric linkage carried out with a subset of the data representing a nuclear family of dogs consisting of 2 
parents, 4 affected and 2 unaffected full siblings. Positive LOD scores (2.501) were found on canine chromosome 20 with a 
critical interval of 20.63 Mb (position 29.33–49.96 Mb). (C) Recap of the different mapping hits obtained through the different 
methods used. Genome regions identified by positive LOD scores in linkage analysis, by homozygosity mapping, and by the 
highest peaks in GWAS are indicated in green, red, and blue, respectively. Note the triple hit on canine chromosome 20.
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The resulting two remaining variants were an insertion (CFA20:g.33,717,704_33,717,705insT, CanFam3.1) in 
the CCDC66 gene (Fig. 4), predicted to cause a frameshift (p.Val747SerfsTer8); and CFA20:g.39,560,171G > A 
(CanFam3.1) in the RNF123 gene predicted to cause a point mutation (c.2755C > T, p.Arg919Cys—predicted by 
Polyphen2 as being “Possibly Damaging”, score 0.81, not sufficient for “Probably Damaging”, a higher probability 
prediction). No large insertion, deletion, duplication or inversion associated with the disease was detected by 
Delly (see "Materials and methods" section).
Of note, during the analysis of the WGS output, another apparently pathogenic CCDC66 variant predicted 
to cause a frameshift (CFA20:g.33,745,456_33,745,457insT, CanFam3.1) also emerged based on deviation from 
Figure 4.  Whole-genome and Sanger sequencing of the disease variant. (A) Screenshot of the whole-genome 
sequencing (WGS) reads of an obligate carrier (parent) at the top and a clinically affected PWD at the bottom. 
Reads are mapped against the canine reference sequence (CanFam3.1). Note the 1-bp insertion in CFA20:g.
33,717,704_33,717,705insT (CanFam3.1) (arrowhead). (B) Sanger sequencing confirmed the presence of the 
homozygous 1 bp insertion in the case. Electropherograms of a control PWD (wild type), one of the parents of 
the affected dogs (carrier), and an affected dog (case) are shown. The position of the variant is indicated with 
an arrowhead. Sanger sequences were produced with a primer in reverse complementary orientation to the 
genome reference sequence. Therefore, the sequence of the carrier has overlapping signals on the left side of the 
heterozygous indel.
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the reference sequence. However, examination of WGS data of over 50 canine genomes in our database that 
were unrelated to the current study and belonged to different breeds found that the additional T residue was in 
fact present in a homozygous state in all genomes examined. The presence of the additional T residue was fur-
ther confirmed by PCR and Sanger sequencing of genomic DNA samples from healthy PWDs. It was therefore 
concluded that the CanFam3.1 reference sequence did not represent the wild type canine sequence at CFA20: 
33,745,456, most likely due to a sequencing error, or possibly due to the presence of a rare variant in the Boxer 
from which the CanFam 3.1 reference genome assembly is derived.
With the identification of the CCDC66 disease variant in PWDs, there are at least two distinct forms of PRA, 
early- and late-onset, confirmed to date in PWDs. Table 1 summarizes the two forms of PRA in PWDs, along 
with another form of PRA which has been associated with a distinct CCDC66 variant in Schapendoes.
Screening of the protein changing candidate variants in the canine population. The potential 
protein changing variants, CCDC66 (c.2262_c.2263insA) and RNF123 (c.2755C > T) identified in our screening, 
were each genotyped in 102 and 132 available PWD samples, respectively (Table 2).
All four EOPRA affected siblings were homozygous mutant for both the CCDC66 (c.2262_c.2,263insA) and 
RNF123 (c.2755C > T) variants, while none of the clinically normal PWDs were homozygous mutant for either 
variant. These two variants, separated by ~ 6 Mb, were in linkage disequilibrium among the four EOPRA cases. 
Genotyping for the RNF123 variant in an extended panel of normal control PWDs did not identify any homozy-
gotes of the variant. Hence, the RNF123 variant could not be conclusively excluded from disease causation by 
screening of available population. However, while the effect of the RNF123 non-synonymous variant remains 
Table 1.  Summary of EOPRA in PWDs and other related diseases.
Disease names used References Breed Onset (y) Gene Disease variant
Possible equivalent disease name 
in humans
prcd-PRA 36 PWD 3–6 PRCD c.5G > A PRCD-RP
EOPRA This paper PWD 2–3 CCDC66 c.2262_c.2263insA CCDC66-RP, CCDC66-LCA
PRA 42 Schapendoes 4–7 CCDC66 c.521_522insA CCDC66-RP
Table 2.  Distribution of CCDC66 and RNF123 variants in PWDs with known phenotypes. Note that greater 
number of normal dogs were screened for the RNF123 variant in an effort to identify homozygotes of the 
RNF123 variant that would allow its exclusion from disease association. *These cases were evaluated and 
examined by referring board-certified veterinary ophthalmologists or accredited eye specialists other than the 
authors.
Retinal phenotype
CCDC66 
c.2,262_c.2,263insA
Total # of dogs
RNF123 
c.2,755C > T
Total # of dogswt/wt wt/A A/A C/C C/T T/T
EOPRA—proband and its siblings, PRCD unaffected, 
early-onset (2-3y) 0 0 4 4 0 0 4 4
PRA*—sporadic cases, PRCD affected, early-onset 
(2-3y) 3 0 0 3 3 0 0 3
PRA*—sporadic case, PRCD unaffected, early-onset 
(2y) 1 0 0 1 1 0 0 1
Normal 69 25 0 94 93 31 0 124
Total # of dogs 73 25 4 102 97 31 4 132
Table 3.  Distribution of the CCDC66 disease variant in populations with and without phenotype information.
Breed and availability of
retinal phenotype
N of 
dogs
CCDC66
c.2,262_c.2,263insA Allele frequency
(%)wt/wt wt/A A/A
PWD – Clinically assessed 102 73 25 4 16.2
PWD – Phenotype unknown 616 602 14 0 1.1
PWD – Total 718 675 39 4 3.3
Other breeds – Phenotype unknown 644 644 0 0 0
GRAND TOTAL 1362 1319 39 4 1.7
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elusive, likely disease causation by the CCDC66 variant is supported by previous association of CCDC66 vari-
ants with RDs in  canine42 and  murine46 models, and our in vitro study below demonstrating altered subcellular 
expression associated with the CCDC66 variant.
We also obtained additional DNA samples of four sporadic PRA cases of PWDs not directly related to the 
proband, with an early age of onset at 2–3 years, atypical for prcd-PRA, and had been diagnosed by certified 
veterinary ophthalmologists but not clinically examined by the authors. Three of these 4 dogs were homozy-
gous for the PRCD variant and none of them were found to harbour the disease haplotype on CFA20 spanning 
CCDC66. Thus, these dogs likely represent the early-extreme of the prcd-PRA spectrum. The fourth case did not 
harbour either the prcd-PRA or CCDC66-EOPRA reported herein (Table 2), indicating a unique genetic origin. 
The CCDC66 variant was screened in 616 additional PWD dogs of unknown phenotype that had been submitted 
for DNA testing service, revealing 14 carriers and no homozygote, with an allele frequency of 1.1% (Table 3).
CCDC66 transcripts, protein isoforms, and impact of the variant. The effect of the CCDC66 vari-
ant on retinal transcripts could not be studied experimentally due to lack of access to ocular tissues from affected 
dogs. Therefore, we carried out extensive analysis of retinal RNA-seq data from normal dogs to first identify nor-
mal transcript isoforms and then to model how the CCDC66 variant could impact translation. The output from 
Stringtie revealed eight predicted transcripts, identified as I to VIII (Fig. 5, Supplementary Data 1), in which to 
examine the potential impact of the variant. Transcript I was the most common at ~ 70% reads in the available 
data and transcripts I and II together comprised more than 90% of all detected CCDC66 transcript reads. Note 
that the limited length of each RNA-seq paired-end reads at 100 bp did not allow for identification of the full 
transcript structure within the same reads, potentially leaving undiscovered minor transcripts. All identified 
transcripts were translated using the Expasy translation tool (https ://web.expas y.org/trans late/). Alignment was 
done among all eight predicted canine isoforms (Supplementary Data 2), canine isoforms with the predicted 
human isoforms obtained from NCBI (Supplementary Data 3), and the full-length canine wild type and mutants 
from other mammals (Fig.  6A, Supplementary Data 4). Taken together, these alignments reveal a predicted 
Figure 5.  Canine CCDC66 full-length transcript and minor isoforms. Predicted canine CCDC66 transcript 
structures derived from control canine retinal RNA-seq data generated by our group for unrelated studies. 
Transcripts are named from I to VIII where transcripts I and II were overwhelmingly more abundant (> 90%) in 
our dataset. The asterisk indicates the position of the CCDC66-EOPRA disease variant described in this paper. 
The transcripts present in our RNA-seq datasets revealed 19 exons when the exitron phenomena were not taken 
into account.
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major heterogeneity of the N-terminus within and across species, and an overall greater abundance of conserved 
regions toward the C-terminus, including the region directly affected by the disease variant. The nomenclature 
of the disease variant is c.2262_c.2263insA for transcript I. 
Translation of the mutant transcript I revealed a mutant protein (p.Val747SerfsTer8) of 755 amino-acids (aa) 
long, while the corresponding wild type canine isoform I predicted to be 951 aa. Thus, the variant results in a 
Figure 6.  Canine CCDC66 protein structures and the implications of the disease variant. (A) Multiple sequence 
alignment of the CCDC66 protein in the region of the frameshift shows the conservation (*) of residues across 
mammals. On top, the canine isoform I is shown, with the positions of the extreme N- and C-terminal amino 
acids shown marked. The conservation (*) does not take the canine mutant (shown in red) into account. The 
position of the predicted coiled-coil (CC) domain is indicated with a yellow bar. (B) Predicted isoforms I and 
II in each the wild type (WT) and the mutated, truncated form (Mut). The length (AAs number) is reported in 
reference of the predicted isoform I. Note the CCDC66 domains, the coiled-coil (CC) and the leucine zipper 
(LZ) as predicted by motif identifiers. The red asterisk indicates the position of the frameshift variant described 
by Dekomien et al.42 (p.208 in isoform I). Note the loss of approximately 20% of the mutated protein and of 
the predicted coiled-coil and leucine zipper sequences in the C-terminal part in the mutant CCDC66 for both 
transcripts I and II.
Figure 7.  In vitro expression of wild type CCDC66 and the truncated mutant CCDC66. Western blot of 
lysates from COS-1 cells transfected with wild type (lane 1) and mutant (lane 2) Myc-tagged canine CCDC66. 
Incubation with anti-Myc antibody revealed expression of the expected full-length Myc-CCDC66 product 
(115 kDa) in lane 1, and a truncated protein (92 kDa) in lane 2 as expected by the disease variant. β-actin served 
as the internal loading control.
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truncated mutant protein (Isoform I) that is 79.4% shorter than the wild type protein. These amino acid align-
ments are shown in Supplementary Data 5.
The predominant transcript I was further analyzed using  Pfam19 to search for known or potential domains 
and functional sequences. While Pfam confirmed a coiled-coil domain at 450–598 aa, another alignment car-
ried out by Interpro identified the same region as a CCDC66 domain (450–598 aa), which is conserved but not 
well characterized, as discussed below. The GO terms predicted were GO:0046548 retinal rod cell development; 
GO:0008017 microtubule binding; and GO:0005813 centrosomes. Additionally, Interpro predicted coiled-coil 
structures in the disease interval that are lost in the mutated protein (741–761 and 915–935 aa). Motifscan pre-
dicted a potential leucine zipper in position (918–939 aa isoform I). Psipred predicted a helix structure in the 
C-terminal region. The predicted wild type and mutated isoform I are shown in Fig. 6B.
Western blot analysis of truncated mutant CCDC66 and immunohistochemical localization of 
CCDC66 in normal canine retina. Western blot analysis was performed on lysates of COS-1 cells trans-
Figure 8.  Localization of CCDC66 in the photoreceptor connecting cilia of normal canine retina. 
Immunohistochemistry in normal canine retinal cryosection demonstrates specific CCDC66 (green) 
immunolabelling of the connecting cilia with lighter labelling of the photoreceptor outer segments. There is also 
faint labelling along the OPL which apposes with Goα (red, ON-bipolar cell marker) indicating the localization 
of CCDC66 in the photoreceptor axon terminals. *blood vessel.
Figure 9.  In vitro localization of wild type CCDC66 and the truncated mutant CCDC66. 
Immunocytochemistry shows wild type Myc-CCDC66 expressed in the cytoplasm with punctate perinuclear 
labelling, and no apparent nuclear localization (A). In contrast, expression of the mutant Myc-CCDC66 is 
largely restricted to the nucleus with faint cytoplasmic expression (B).
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fected with constructs encoding either the wild type or mutant CCDC66 with N-terminal Myc tags. The c-Myc 
(9E10) antibody was used to probe the Myc-CCDC66 protein complex. Immunoblot analysis showed bands 
of 115 kDa and 92 kDa (Fig. 7, Supplementary Fig. 2) corresponding to the Myc-tagged wild type and mutant 
CCDC66 proteins, respectively. The semi-quantitative result confirms the expression of the truncated mutant 
protein at levels comparable to that of the wild type. While affected canine retina was not available, we carried 
out immunohistochemistry in normal canine retina to validate the localization of CCDC66. Immunolabelling 
with anti-CCDC66 antibody revealed light labelling of the outer segment with specific and intense signals in 
the connecting cilia suggesting that this protein plays a role in ciliary function (Fig. 8). There was also some less 
intense labelling in the OPL, which was likely to be in the photoreceptor axon terminals based on apposing with 
Goα, an ON-bipolar cell marker.
Nuclear mislocalization of mutant CCDC66 compared to wild type CCDC66. To examine the 
subcellular localization of CCDC66 proteins, wild type and mutant canine CCDC66 cDNAs were each cloned 
into expression vectors with N-terminal Myc tags. COS-1 cells were transfected with each of these constructs 
individually, fixed, and probed with anti-Myc antibody. Immunocytochemistry revealed that wild type Myc-
CCDC66 was expressed in the cytoplasm with a faint reticular pattern and punctate perinuclear labelling, with 
no apparent labelling in the nuclei (Fig. 9A). In contrast, expression of the mutant Myc-CCDC66 was largely 
restricted to the nucleus, with faint cytoplasmic expression (Fig. 9B). These findings suggest that mislocalization 
of CCDC66 in disease retinas can affect its role in the photoreceptor sensory cilia.
Discussion
Through a combined approach of SNP genotyping, WGS, and population screening, we have identified a genetic 
variant in CCDC66 associated with a newly characterized canine RD, namely EOPRA, in PWDs. CCDC66 vari-
ants have been associated with RD in  mice46 and  dog42, supporting its functional role in EOPRA. We have shown 
that the CCDC66 variant can give rise to a truncated protein that mislocalizes to the nucleus, further indicating 
that its altered function contributes to the disease phenotype. While a second genetic variant in RNF123 that 
was in linkage disequilibrium with the CCDC66 variant was also identified in the family of the proband, RNF123 
variants has not previously been associated with a retinal phenotype. As CCDC66 variants have been previously 
implicated in retinal diseases, we believe that our newly identified CCDC66 variant is causative for EOPRA.
Interestingly, the four affected PWDs with early onset not directly related to the proband did not harbour 
either CCDC66 or RNF123 variant. Of these dogs, three were homozygous for the prcd-PRA (PRCD) variant 
which has previously been found to segregate in the breed as late-onset PRA. As these dogs are not affected by 
the variant responsible for EOPRA, it suggests that these cases represent the early extreme of the spectrum of 
prcd-PRA. The fourth affected dog did not harbour the affected haplotype on CFA20 mapped herein or the prcd-
PRA (PRCD) variant, suggesting that the disease in this dog is caused by an, as yet unidentified, genetic variant.
The CCDC66 frameshift disease variant is predicted to truncate the C-terminus of the CCDC66 protein to 
roughly 80% of its original length. As tissues from affected dogs homozygous for the CCDC66 variant were not 
available for analysis, we cloned wild type and mutant canine CCDC66 into expression vectors for in vitro assays. 
Western blot results indicate that the mutated protein is translated and detectable, albeit truncated. Moreover, 
in vitro overexpression of CCDC66 in cultured COS-1 cells reveal altered subcellular localization in the mutant 
compared to the wild type, indicating a potentially defective function of the mutant CCDC66.
While the identified disease-associated genetic variant affects the C-terminus of CCDC66, the functional 
domains within this protein remain virtually unknown. Search for motifs based on the canine CCDC66 sequence 
using algorithms such as pfam, Motifscan, Interpro and Psipred confirmed the presence of the CCDC66 domain, 
upstream of the disease variant. These software programs also identified additional recognizable patterns (i.e. 
helix structures, coiled-coils and leucine zippers) some of which were missing in the truncated mutant protein. 
Alignment of the amino acid sequences with human CCDC66, as well as with CCDC66 in other mammals 
(Fig. 6; Supplementary Data 3 and 4), show a degree of conservation in the C-terminus. Taken together, these 
data suggest that the C-terminus of the CCDC66 protein has important functional relevance that is impacted 
by the frameshift variant.
Although we recently identified EOPRA as a new form of PRA in PWD, prcd-PRA caused by a genetic 
variant in PRCD36 has been known to affect the breed for over 10 years. Of particular note, prcd-PRA, which is 
categorized as late-onset PRA, is the most widespread form of PRA, having been reported in nearly 60 canine 
breeds and their crosses. While the associated PRCD genetic variant is identical across the many diverse breeds, 
the age of disease onset varies by breed, indicating that the genomic background unique to each breed affects 
disease progression. However, within individual breeds, the age of onset is much more predictable and the typi-
cal clinical disease onset of prcd-PRA in PWDs is 3–6 years or  older14,40. Using the commercially available DNA 
test to detect the PRCD variant, the PWD breeding community has been encouraged to avoid breeding choices 
that can produce prcd-PRA affected puppies.
The four PWD cases in which we identified a new CCDC66 disease variant (c.2262_c.2263insA) herein had 
an early disease onset at 2–3 years. Meanwhile, another variant in CCDC66 associated with PRA in Schapendoes 
 dogs42, in which a homozygous 1-bp insertion in exon 6 (c.521_522insA) leads to an immediate stop codon, had 
a disease onset of 4–7 years of age. Such difference in disease expression could be driven by the specific functional 
impairment caused by each CCDC66 genetic variant or by difference in breed-specific genomic backgrounds 
and environmental factors that modify the phenotype. Dekomien et al. suggested that the CCDC66 variant in 
Schapendoes was expected to truncate the CCDC66  protein42. In the case of PWDs, we were able to detect a 
truncated protein encoded by the mutant CCDC66. These results indicate that the mutant CCDC66 derived 
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from the CCDC66 variant in PWDs—occurring further downstream than in Schapendoes—is not subject to 
non-sense mediated decay and instead gives rise to a detectable amount of protein.
Dekomien and colleagues also studied a genetically-modified Ccdc66−/− mouse model that lacked Ccdc66 
expression and had a retinal phenotype. Their studies also indicated that CCDC66 protein primarily exists as 
dimers and that the coiled-coil domain may participate in protein–protein  interactions42. Remarkably, Gerding 
et al. demonstrated that Ccdc66 knockout in mice leads to early photoreceptor degeneration, with progressive reti-
nal phenotype and physiological impairment of the  retina46. ERG in these mice pointed to primary rod degenera-
tion accompanied, to a lesser extent, by cone degeneration, following a time course comparable to RP in humans 
rather than other more rapidly progressive RP mouse models. In a more recent study, a substantial olfactory 
nerve fiber degeneration and alteration of olfaction-related behavior was described in aged Ccdc66−/−  mice47. 
As both photoreceptors and olfactory sensory neurons that undergo degeneration are ciliated, Ccdc66−/− mice 
appear to represent a ciliopathy-like disease. Indeed, early-onset retinal dystrophies and degeneration are often 
part of the syndromic phenotype of  ciliopathies7,8,48.
Despite being identified in  201042, the potential functions of CCDC66 are only beginning to surface. Notably, 
CCDC66 is required for efficient ciliogenesis and centriolar satellite  distribution48. Co-immunoprecipitation 
experiments demonstrated that CCDC66 interacts with numerous proteins that function in ciliogenesis (i.e. 
CEP72, CEP290 and PCM1) and CEP290 has also been previously implicated in retinal degeneration in human 
ciliopathies and mouse  models49. Overexpression of CCDC66 disrupts organization of centriolar satellites and 
inhibits primary cilium formation. In our current study, in vitro expression of wild type canine CCDC66 in 
COS-1 cultured cells was suggestive of a microtubular expression pattern, which was compromised by the mutant 
canine CCDC66, resulting in its nuclear accumulation. Based on the critical role of microtubules in the integrity 
of photoreceptor connecting cilium, and the presence of specific CCDC66 labelling in the connecting cilia of 
photoreceptors in normal canine retina, our findings warrant further investigation as to whether mislocalization 
of CCDC66 variants may result in ciliopathies with retinal manifestations.
More recently, the role of CCDC66 in human RDs has been challenged by Khan and colleagues, who con-
cluded that a c.2649delA (p.Lys883AsnfsTer20) variant in CCDC66 is not causative for the condition in patients 
based on the absence of the variant in one affected sibling in an affected family segregating  RD50, as well as 
homozygosity in a different individual from an allegedly healthy sample pool from the Greater Middle  East51. 
While variants closer to the N-terminus causing RD could not be excluded, the authors instead suggest that a 
genetic variant in NMNAT1 was responsible for the RD in the patients investigated. However, our data demon-
strating complete co-segregation of the CCDC66 genotype with the EOPRA phenotype in PWDs support the 
essentiality of the role of CCDC66, and support CCDC66 as suitable candidate gene underlying RDs.
Although no variants in CCDC66 have been definitively mapped to human ciliopathies, CCDC66 variants 
have been associated with RD in dogs and mouse. While mouse models often fail to completely recapitulate the 
human phenotype of  ciliopathies52–54 and variants in the same genes can lead to dramatically different phenotypes 
 across55 and even  within56 mammalian species, it remains possible that as yet uncharacterized human CCDC66 
variants may still contribute to disease. Indeed, our preliminary data and previous work by  others42,46 suggest that 
CCDC66 is subject to alternative splicing events which are still incompletely characterized. Thus, the impact of 
genetic variants must be carefully analysed and should be weighed against the prevalence of certain transcripts 
specific to the tissue of interest.
Here, we show that expression of wild type canine CCDC66 in COS-1 cells results in a cytoplasmic expression 
pattern, but that the EOPRA disease variant accumulates within the nucleus (Fig. 9). Our findings strongly sug-
gest that localization of the mutant CCDC66 within the nucleus impairs its physiological function, thus leading 
to the RD phenotype. Conkar and colleagues previously used ciliated RPE1 cells to functionally and biochemi-
cally characterize  CCDC6648. The authors showed that CCDC66 localizes to the centrosome and the centriolar 
satellites, redistributing between centriolar satellites and the primary cilium in ciliated cells. Interestingly, the 
group also expressed the variant CCDC66 described by  Dekomien42 and showed the mutant CCDC66 localized 
diffusely throughout the cytoplasm and nucleus (Fig. S2 in the Conkar paper, showing other truncated forms). 
The authors suggested that the RD phenotype might result from disruption of the localization and interactions of 
CCDC66 in cells, a conclusion consistent with our findings. Further analysis of the effect of our identified variant 
awaits expansion of the research colony so that affected animals/tissues can be analysed in detail to inform on 
the direction and approach of in vitro studies.
Conclusions
In this paper, we show that the SNP genotyping allowing both GWAS and linkage analysis, and a combined 
approach with WGS is a powerful tool to study the molecular basis of inherited diseases in dog. We were able to 
successfully map an exonic 1 bp insertion variant that leads to a premature stop codon in CCDC66, a gene pre-
viously implicated in RD. Based on the expression of a truncated and mislocalized mutant CCDC66 protein 
in vitro, we propose this variant as causative for EOPRA in PWDs. This disease variant occurs downstream of 
the CCDC66 domain, the function of which remains to be characterized. Nonetheless, the interval truncated in 
the mutant protein is conserved in mammals and motif predictions suggest structural patterns with potential 
functional significance.
CCDC66 is the second gene, after PRCD, in which a genetic variant has been associated with PRA in PWDs, 
demonstrating locus heterogeneity within a breed. In addition, allelic heterogeneity can occur between breeds, 
as the CCDC66 genetic variant reported herein differs from the variant previously found associated with PRA 
in the Schapendoes breed.
Reports of CCDC66 genetic variants occurring in dogs and mice have all pointed to the role of CCDC66 in 
RD. Our findings in the newly characterized canine model suggest that the role of CCDC66 in normal retinal 
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function warrants further investigation, including functional assessment of human CCDC66 as well as screening 
for CCDC66 variants in RD patients whose underlying genetic variants have not been accounted for, particularly 
if there are indications of ciliopathy.
Materials and methods
Ethical statement. The research was conducted in full compliance and strict accordance with the Associa-
tion for Research in Vision and Ophthalmology (ARVO) Resolution on the Use of Animals in Ophthalmic and 
Vision Research. The protocol was approved by the Institutional Animal Care and Use Committees (IACUCs) of 
the University of Pennsylvania (#806301).
Sample collection and phenotype assessment. All the cases affected with EOPRA (n = 4) along with 
control PWDs (n = 78) directly or remotely related to the cases were clinically ascertained by board-certified vet-
erinary ophthalmologists (KM, GDA). In addition, samples from normal control PWDs (n = 20) were submit-
ted from their owners along with detailed questionnaire related to vision and where available, eye examination 
results. In the exceptions (n = 4) where the animals were not available for examination by the authors, reports of 
PRA with onsets at 2–3 years of age from other board-certified veterinary ophthalmologists or accredited eye 
specialists were referred to.
All examinations were done by indirect ophthalmoscopy and biomicroscopy after pharmacologic dilation as 
stipulated by the ACVO guidelines for screening eye examinations. For selected cases, fundus photographs were 
taken using a fundus camera (Genesis-D; Kowa Ltd, Nagoya, Japan) by direct photography or indirect photog-
raphy through a 20D  lens44. Blood samples were collected in EDTA tubes for DNA extraction. For each dog, eye 
examination records, and where possible, pedigree information, were obtained. All the clinical information was 
reviewed by board-certified veterinary ophthalmologists (KM, GDA) prior to inclusion of each animal in the 
study. Electroretinography was carried out in one dog based on protocols previously  described57.
Animals and single nucleotide polymorphism (SNP) genotyping. Blood-derived genomic DNA 
samples from a total of 23 PWDs (4 affected and 19 unaffected) were used for SNP chip genotyping. Among 
these samples, there was a subset of closely related dogs consisting of the 4 EOPRA cases, their 2 unaffected 
full-siblings, and the 2 unaffected parents. DNA was extracted with the Illustra DNA extraction kit BACC2 (GE 
Healthcare) following manufacturer’s instructions. Genotyping was performed using the CanineHD BeadChip 
(Illumina) that includes 173,661 evenly distributed SNPs, and following standard protocols as recommended 
by the manufacturer. Additional PWD DNA derived from blood or cheek swab samples were genotyped in-
house or through the Optigen research program for the PRCD variant using established  methods36 and for the 
CCDC66 and RNF123 genetic variant as described below.
Genome‑wide association. For GWAS, we used the GenABEL package (https ://cran.r-proje ct.org/src/
contr ib/Archi ve/GenAB EL/, v 1.8) developed for the R Studio integrated  environment58 (https ://rstud io.com/, 
v 0.99.903). As a preliminary step for the analysis, we used the standard quality control settings to remove 
markers and individuals with call rates < 90%, markers with minor allele frequency (MAF) < 5%, and markers 
strongly deviating from Hardy–Weinberg equilibrium. The preliminary MDS plot and ancestry analysis expect-
edly pointed out a stratified population, therefore the analysis was followed by a mixed model association study 
as designed in the GenABEL package. The Manhattan plot was analyzed to search for suggestive or associated 
peaks.
Homozygosity mapping and phasing. The GWAS analysis was followed by a homozygosity mapping 
approach, carried out with PLINK (https ://www.cog-genom ics.org/plink 2 v 1.9)59 to detect extended intervals 
of homozygosity with shared alleles, and to fine-map the region containing the responsible genetic variant. 
The dataset consisted of 173,661 evenly spaced SNPs. Individuals and SNPs were selected using the commands 
“--keep”, and “--extract”. Homozygosity analysis was performed on all cases using the commands “--dog”, 
“--homozyg” and “--homozyg-group”.
Linkage. To prepare the dataset for linkage analysis, the PLINK (https ://www.cog-genom ics.org/plink 2 v 
1.9)59 software was used with the “--dog” command to account for the species-specific chromosome quantities. 
The genotype data was pruned to remove SNPs that had either > 10% missing genotype calls, had a minor allele 
frequency of < 5%, or exceeded the Hardy–Weinberg disequilibrium p value of 0.0001 (“geno 0.1”, “--maf 0.05”, 
“--hwe 0.0001”). Subsequently, the MERLIN (https ://csg.sph.umich .edu/abeca sis/Merli n/downl oad/, v 1.1.2) 
 software60 was used to carry out the parametric linkage analysis under the assumption of a recessive mechanism 
of inheritance. The dataset consisted of 8 dogs: 6 full-siblings (4 affected and 2 unaffected) and their 2 obligate 
carrier parents. The “--error” command was applied to filter out Mendelian errors. The linkage for the each of 
the autosomes was carried out in the following manner: multipoint LOD scores was calculated using a model for 
mono-allelic autosomal recessive trait; we assumed for the calculation a complete penetrance and a frequency of 
the mutated allele of 0.68. MINX, part of the MERLIN package and tailored for X-chromosome linkage analysis, 
was used to analyze the X chromosome, with the same parameters previously described.
Since we analyzed a small family with a reduced number of samples (8-individuals in total), any positive LOD 
score obtained was accepted as possible indication of linkage. The graphical representation of the analysis was 
obtained in MERLIN using the “--pdf ” option.
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Whole‑genome sequencing. Three DNA fragment libraries were prepared from samples derived from a 
case-parent trio (1 affected dog and its 2 obligate carrier parents). Libraries of 300 bp insert size was prepared, 
llumine HiSeq2500 paired-end reads (2 × 100 bp) were collected one lane per sample, and the fastq files were 
created using Casava (https ://biowe b.paste ur.fr/packa ges/pack@casav a@1.8.2, v 1.8.2). A total of 1,637,397,795 
reads (100 bp paired-end reads) were collected for the three dogs from a shotgun fragment library (correspond-
ing to an approximate average 32.6 × coverage of the genome). The paired-end reads were then mapped to the 
dog reference genome CanFam3.1. The reads were aligned using Burrows-Wheeler Aligner (BWA, http://bio-
bwa.sourc eforg e.net/, v 0.5.9-r16)61 with default settings. The SAM file which was generated by BWA was then 
converted to a BAM file and the reads were sorted by chromosomes using samtools (http://www.htsli b.org/, v 
1.1)62. The PCR duplicates were marked using Picard tools (http://sourc eforg e.net/proje cts/picar d/).
Variant discovery. For variant calling and data alignment, the GATK (https ://gatk.broad insti tute.org/hc/
en-us, v 2.4.9)  program63 was used in the “unified genotyper” mode. The output data was produced in variant 
call format (vcf, version 4.0); the raw calls for all samples and sites were flagged using the standard variant filtra-
tion module of GATK; such variant filtration was executed in accordion to the “best practice” documentation 
of GATK (version 4). The prediction of the functional effects of the detected variants was carried out using the 
software SnpEff (https ://pcing ola.githu b.io/SnpEff /, v 5.0)64, comparing the data with the CanFam3.1 assembly 
. The final list of the variants exclusive to the PWD samples was obtained filtering them from the Dog Bio-
medical Variant Database Consortium (DBVDC), using the software BCFtools (https ://samto ols.githu b.io/bcfto 
ols/, v 1.11)61,65. Further filtering was carried out using the DogSD (https ://bigd.big.ac.cn/dogsd v2/, accessed 
9/24/2020) and the European Variation Archive variant browser (https ://www.ebi.ac.uk/eva/?Varia nt-Brows 
er, accessed 9/24/2020) as additional source of variants. The accession numbers of the available bam files are 
reported in File S8. Furthermore, the Delly2 program (https ://githu b.com/delly tools /delly , v 0.8.5)66 was used 
to detect structural variants in the three BAM files. The same software was used to validate the suspected vari-
ants in the same cohort of the affected case and the two sequenced parents, plus 10 canine .bam files sequenced 
by the authors in studies unrelated to the PWD work reported herein. The commands for deletions, insertions, 
inversion and duplications were all executed separately. The analysis was carried out focusing on the candidate 
region evidenced by mapping.
PCR and Sanger sequencing. The genetic variants in RNF123 and CCDC66 were verified in all the avail-
able PWD samples, by re-sequencing of targeted PCR products using Sanger sequencing. PCR products were 
sequenced on an ABI 3730 capillary sequencer (Life Technologies, Carlsbad, CA) after treatment with ExoSAP-
IT (Thermo Fisher Scientific, Waltham, MA). Sequence data were analyzed using Sequencher (http://www.genec 
odes.com/, v 5.1, GeneCodes). Primer sequences are available upon request.
Transcript characterization. The CCDC6 mRNA was annotated using SPLIGN (https ://www.ncbi.nlm.
nih.gov/sutil s/splig n/splig n.cgi) with the human transcript NM_024503.4 as template. Stringtie (https ://ccb.jhu.
edu/softw are/strin gtie/, v 2.13)67 was used with a dataset of 8 samples of canine retinal RNA-seq produced in 
our lab for unrelated studies as a reference to re-annotate CCDC66 transcripts and to detect alternate splicing. 
Further, the predominant, full-length canine CCDC66 cDNA was amplified by RT-PCR and subjected to Sanger 
sequencing for confirmation of the exon structure and the cDNA sequence.
Sequence alignment. The transcript sequences obtained were aligned to the predicted sequences of other 
mammals using Clustal Omega (https ://www.ebi.ac.uk/Tools /msa/clust alo/)68. Furthermore, each transcript 
was converted into protein sequences using the Expasy translation tool (https ://web.expas y.org/trans late/). Each 
predicted protein sequence obtained was aligned using Clustal Omega against the human sequences and the 
conserved regions were marked. Additionally, the predicted proteins from CCDC66 transcripts I and II were 
submitted to Pfam-sequence search (https ://pfam.xfam.org/)19 for the prediction of known/potential domains 
and functional sequences. Additional alignments were carried out by Interpro (https ://www.ebi.ac.uk/inter 
pro/)69, Motifscan (https ://myhit s.isb-sib.ch/cgi-bin/motif _scan), and Psipred (http://bioin f.cs.ucl.ac.uk/psipr 
ed/)69. RNF123 variant impact predicted with Polyphen-2 (http://genet ics.bwh.harva rd.edu/pph2/)70.
Cloning of cDNA constructs into expression vectors and cell transfection. Retinal RNA was 
extracted from a wild type canine retina, and CCDC66 cDNA was amplified by RT-PCR. Two non-synonymous 
variants were found in this wild type retina affecting relatively well conserved amino acids. These were corrected 
to match the reference sequence using NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs, 
Ipswich, MA). The same kit was used to introduce the CFA20:g.33,717,704_33,717,705insT mutation to con-
struct the mutant version of CCDC66 cDNA. Full-length wild type and mutant canine CCDC66 cDNA was each 
cloned into pKMyc vectors (Addgene, Cambridge, MA) to create N-terminal Myc-tagged  constructs71. African 
green monkey kidney fibroblast-like cell line (COS-1) (ATCC, Manassas, VA; cat. #CRL-1650; lot #59102713) 
was cultured in DMEM with 10% foetal bovine serum and 10U/mL penicillin/streptomycin with an atmosphere 
of 5%  CO2 at 37 °C. Cells were seeded and grown to 70–90% confluency in glass cell culture chamber slides and 
transfected with either of the recombinant expression vectors or a control ‘empty’ vector using Lipofectamine 
3000 (Invitrogen, Thermo Fisher Scientific), according to manufacturer’s protocol. After 48 h of transfection, 
cells were subjected to immunocytochemistry or harvested for Western blot analysis.
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Western blot analysis. Extracts of transfected cells were prepared in RIPA buffer (Thermo Scien-
tific, Waltham, MA, USA) containing a protease and phosphatase inhibitor cocktail (Halt, Thermo Scientific, 
Waltham, MA, USA). The cells were first homogenized by vortexing and left on ice for 15 min. The samples were 
then centrifuged and a total protein concentration in the supernatant was assessed by Bradford assay. From each 
sample, 60 µg of total protein was denatured at 95 °C for 5 min in 1X Laemmli sample buffer (Bio-Rad, Hercules, 
CA, USA) and 5% 2-mercaptoethanol. Protein samples were then resolved on a 4–12% Bis–Tris gel (Invitrogen, 
Carlsbad, CA, USA) in 1X SDS/Tris/Glycine buffer, transferred to a nitrocellulose membrane (Bio-Rad, Hercu-
les, CA, USA) and blocked with 1X Odyssey PBS Blocking Buffer (LI-COR, Lincoln, NE, USA) for 1 h at room 
temperature. The membrane was then probed with anti-c-Myc (1:1,000) (9E10, Cell Signaling, Danvers, MA, 
USA) and anti-β-Actin (1:2,000) (ab8227) (Abcam, Cambridge, UK) for normalization at 4 °C for 18 h. After 
incubation with infrared dye-tagged secondary antibodies (LI-COR, Lincoln, NE, USA), immunoblots were 
washed thrice in PBS-Tween 20 (0.1%) with a final wash in PBS. Protein bands were visualized on a digital imag-
ing system (Odyssey FC, LI-COR, Lincoln, NE, USA).
Immunohistochemistry (IHC). Tissue preparation, sectioning and IHC were done as previously 
 described72. Briefly, cryosections were blocked for 1 h in PBS solution containing 0.25% Triton X-100, 3% nor-
mal horse serum, 1% BSA and 0.1% gelatin from cold water fish skin, followed by overnight incubation in 
primary antibody. After PBS washes, secondary antibody conjugated with Alexa Fluor (Molecular Probes) was 
incubated for 2 h at room temperature. DAPI was used as a counterstain and slides were then mounted in Pro-
Long Glass Antifade (Invitrogen). Epifluorescence microscopy was examined with a Zeiss Axioplan microscope 
(Zeiss) and images were digitally captured using SPOT 4.0 software and camera. Images were arranged using 
graphic software ImageJ (NIH).
Immunocytochemistry. Cells were washed with ice cold PBS and fixed in 4% paraformaldehyde for 
15  min. Fixed cells were washed in PBS, permeabilized in PBS containing 0.25% Triton X-100 (PBST), and 
blocked for 15 min in PBST containing 5% bovine serum albumin and 4.5% fish gelatin. Fixed cells were incu-
bated with mouse monoclonal c-Myc antibody (9E10) (Cell Center, University of Pennsylvania) overnight at 
4  °C. The cells were then washed in PBS prior to being incubated with the Alexa-Fluor secondary antibody 
(1:200) (Invitrogen, Thermo Fisher Scientific) in the dark for 1 h. The cells were again washed in PBS and then 
incubated in Hoechst solution (1:1000) (Invitrogen, Thermo Fisher Scientific) to stain the cell nuclei. Cells were 
washed and mounted in Gelvatol mounting medium (containing polyvinyl alcohol and glycerol). Immuno-
fluorescence was visualized with an epifluorescence microscope (Axioplan, Carl Zeiss Meditec, Oberkochen, 
Germany) and images were digitally captured using Spot 4.0 camera.
Data availability
The whole-genome sequencing datasets generated and analysed during the current study are available in the 
European Nucleotide Archive (ERS4045175-77 (SAMEA6245499-501)). All data generated or analysed during 
this study are included in this published article (and its Supplementary Information files).
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